GAIN THERAPEUTICS, INC Deferred Tax Assets, Operating Loss Carryforwards, Domestic
GAIN THERAPEUTICS, INC (GANX) had Deferred Tax Assets, Operating Loss Carryforwards, Domestic of $9.99 million as of 2025-12-31, per its 10-K filed 2026-03-26.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross › Deferred Tax Assets, Operating Loss Carryforwards, Components
us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic · last filed 2026-03-26
- 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Domestic $9.99M.
- 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Domestic $10.41M.
- 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Domestic $7.66M.
- 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Domestic $6.28M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards, Domestic |
|---|---|
| 2025-12-31 | $9.99M 10-K · filed 2026-03-26 |
| 2024-12-31 | $10.41M 10-K · filed 2026-03-26 |
| 2023-12-31 | $7.66M 10-K · filed 2025-03-27 |
| 2022-12-31 | $6.28M 10-K · filed 2024-03-26 |
| 2021-12-31 | $1.68M 10-K · filed 2023-03-23 |
| 2020-12-31 | $146.45K 10-K · filed 2022-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 | |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B |